Biomatter Designs Company
Pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Vilnius, Vilniaus Apskritis, Lithuania
Founded Date:
2018-01-01
Last Funding Date:
2021-01-11
Total Funding:
608000.0
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Employee Number:
11-50
Investors Number:
2.0
Industry:
Early Drug Development